Abstract  Description  Claims  Search report  Cited references 

US5210015A   [0043] 
US5487972A   [0043] 
WO9513399A   [0043] 

Current Protocols in Molecular Biology   [0034] 
Current Protocols in Molecular Biology   [0045] 
Molecular Cloning (A Laboratory Manual)   [0045] 
Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials   [0066] 
Second-generation antipsychotics for major depressive disorder and dysthymia   [0066] 
Adjunctive atypical antipsychotic treatment for major depressive disorder: a meta-analysis of depression, quality of life, and safety outcomes   [0066] 
Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies   [0066] 
Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: a review of the randomized controlled studies   [0066] 
The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease   [0066] 
Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis   [0066] 
Summary of the comparative effectiveness review on off-label use of atypical antipsychotics   [0066] 
Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research   [0066] 
Genetics of antipsychotic treatment emergent weight gain in schizophrenia   [0066] 
Antipsychotic drugs: importance of dopamine receptors for mechanisms of therapeutic actions and side effects   [0066] 
Monozygotic twins concordant for response to clozapine   [0066] 
Body weight gain induced by atypical antipsychotics: an extension of the monozygotic twin and sib pair study   [0066] 
Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications   [0066] 
Anatomy and regulation of the central melanocortin system   [0066] 
GABA release from proopiomelanocortin neurons   [0066] 
GABAergic signaling by AgRP neurons prevents anorexia via a melanocortin-independent mechanism   [0066] 
Synaptic release of GABA by AgRP neurons is required for normal regulation of energy balance   [0066] 
Food intake after diazepam, morphine or muscimol: microinjections In the nucleus accumbens shell   [0066] 
Palatability-dependent appetite and benzodiazepines: new directions from the pharmacology of GABA(A) receptor subtypes   [0066] 
Enhanced sucrose pellet consumption induced by benzodiazepine-type drugs in squirrel monkeys: role of GABAA receptor subtypes   [0066] 
The effects of intraperitoneal administration of the GABA(B) receptor agonist baclofen on food intake in CFLP and C57BL/6 mice   [0066] 
Six new loci associated with body mass index highlight a neuronal influence on body weight regulation   [0066] 
The involvement of GABA(A) receptor in the molecular mechanisms of combined selective serotonin reuptake inhibitor-antipsychotic treatment   [0066] 
Regional specific effects of clozapine and haloperidol on GABA and dopamine release in rat basal ganglia   [0066] 
The effects of chronic haloperidol administration on GABA-immunoreactive axon terminals in rat medial prefrontal cortex   [0066] 
Olanzapine and clozapine increase the GABAergic neuroactive steroid allopregnanolone in rodents   [0066] 
Role of neuroactive steroid allopregnanolone in antipsychotic-like action of olanzapine in rodents   [0066] 
Alterations to melanocortinergic, GABAergic and cannabinoid neurotransmission associated with olanzapine-induced weight gain   [0066] 
Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis   [0066] 
DSM-IV   [0066] 
Structured Clinical Interview for DSM-IV axis I disorders-Research Version (SCID-I/P, version 2.0, February, Final Version)   [0066] 
Systematic analysis of dopamine receptor genes (DRD1-DRD5) in antipsychotic-induced weight gain   [0066] 
Clozapine in treatment-resistant schizophrenics   [0066] 
The brief psychiatric rating scale   [0066] 
Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients   [0066] 
Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder   [0066] 
A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies   [0066] 
Variations in GABRA2, encoding the alpha 2 subunit of the GABA(A) receptor, are associated with alcohol dependence and with brain oscillations   [0066] 
Confirmation of association of the GABRA2 gene with alcohol dependence by subtype-specific analysis   [0066] 
The role of GABA(A) receptors in the development of alcoholism   [0066] 
Human gamma-aminobutyric acid A receptor alpha2 gene moderates the acute effects of alcohol and brain mRNA expression   [0066] 
Gamma-aminobutyric acid receptor genes and nicotine dependence: evidence for association from a case-control study   [0066] 
GABRA2 alleles moderate the subjective effects of alcohol, which are attenuated by finasteride   [0066] 
Variation in GABRA2 predicts drinking behavior in project MATCH subjects   [0066] 
Identification of significant association and gene-gene interaction of GABA receptor subunit genes in autism   [0066] 
A polymorphism in GABRA2 is associated with the medial frontal response to alcohol cues in an fMRI study   [0066] 
The role of brain-derived neurotrophic factor (BDNF) gene variants in antipsychotic response and antipsychotic-induced weight gain   [0066] 
Haploview: analysis and visualization of LD and haplotype maps   [0066] 
Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data   [0066] 
A new statistical method for haplotype reconstruction from population data   [0066] 
Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix   [0066]